Cosmetic Surgery in San Diego

Moradi M.D. - Plastic & Cosmetic Surgery Blog

Monday, December 29, 2008

From Facials to Facelifts and Everything in Between

Happy Holidays!

Come see what makes our office different than other cosmetic surgery centers. We offer the full spectrum of cosmetic rejuvenation, minimally invasive, to full facial plastics, non-abrasive skin rejuvenation to full laser resurfacing.

Facts you should know about us:
A warm and friendly staff, state of the art technology, experienced and talented doctors.

Regg V. Antle, MD

RVA/mm

Sunday, December 21, 2008

Best Facelift

What is the best facelift?

Dr. Moradi believes the best facelift is one that makes the patient look more than 10 years younger and would last for their life time.

To accomplish this, the incisions must be placed at a location that is least visible. For the most natural lift the muscle layer under the skin must be released and elevated to accomplish a natural appearance. The goal is to make one look like their younger self and not someone else. Many advertised facelifts do not accomplish this and entice patients by advertising fast recovery, but at the cost of unsatisfactory results.

The surgeon performing the facelift must be properly trained and very skilled. There are many vital structures such as nerves and arteries in this area and the surgeon must be knowledgeable and meticulous to achieve a comprehensive lift with minimal risks to these structures.

Dr. Moradi is a Board Certified Facial Plastic and Reconstructive Surgeon.


AM/mm

Friday, December 5, 2008

Botox® rival Reloxin® could go on sale in U.S. next year

Botox® challenger Reloxin® could reach the U.S. marketplace next year.

Its corporate sponsors, Medicis® Pharmaceutical of Scottsdale, Ariz., and Ipsen filled their application for Food and Drug Administratin.

Medicis said it is hoping for FDA action on the application by early 2009.

Ipsen makes the drug, a dilute form of botulinum toxin similar to Botox, and sells it in about 20 countries under the name Dysport. If the two companies win FDA clearance, Medicis would market it in the United States under the name Reloxin.

Botox, made by Irvine-based Allergan®, is the No. 1 cosmetic medical treatment in the United States, with more than 3 million injections in 2006, according to the American Society for Aesthetic Plastic Surgery. Medicis estimated that the U.S. market for cosmetic botulinum toxin injections totals $300 million to $400 million.

Our Practice has been the #1 Botox® provider in the entire San Diego County. And our physicians have trained many other physicians in the use of Botox.

As our commitment to our patient we will also try to be at the forefront when Reloxin® enters the market.


Amir Moradi, M.D.

AM/mm
(760) 726-6451 From Facials to Face Lifts E-Mail
>